NUP214-ABL1 amplification in t(5;14)/HOX11L2-positive ALL present with several forms and may have a prognostic significance.
Ballerini
P
P
Busson
M
M
Fasola
S
S
van den Akker
J
J
Lapillonne
H
H
Romana
S P
SP
Marynen
P
P
Bernard
O A
OA
Landman-Parker
J
J
Berger
R
R
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D002883:Chromosomes, Human, Pair 14 / Q000235:genetics*; D002895:Chromosomes, Human, Pair 5 / Q000235:genetics*; D020732:Cytogenetic Analysis; D015973:Gene Expression Regulation, Leukemic; D016313:Genes, abl / Q000235:genetics*; D018398:Homeodomain Proteins / Q000235:genetics*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D028861:Nuclear Pore Complex Proteins / Q000235:genetics*; D015513:Oncogene Proteins / Q000235:genetics*; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000235:genetics*; D011379:Prognosis
D000970:Antineoplastic Agents; D018398:Homeodomain Proteins; C085914:NUP214 protein, human; D028861:Nuclear Pore Complex Proteins; D015513:Oncogene Proteins; D015514:Oncogene Proteins, Fusion; C489494:TLX3 protein, human